Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports
- Lim, S.
- Gillis, D.
- Smith, W.
- Hissaria, P.
- Greville, H.
- Peh, C.
Publication date
January 2006
DOI Publisher
Wiley ISSN
1444-0903 Journal
Internal Medicine Journal Citation count (estimate)
21Abstract
Rituximab is a chimeric monoclonal antibody specific for human CD20 that causes selective transient depletion of the CD20+ B-cell subpopulation. We report the first case of systemic lupus erythematosus (SLE) pneumonitis resistant to conventional treatments that responded well to rituximab and review current reports on the use of rituximab in SLE.S.W. Lim, D. Gillis, W. Smith, P. Hissaria, H. Greville and C.A. Pe
Add to ORKG